Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 187

1.

Chronic Fatigue Syndrome: The Current Status and Future Potentials of Emerging Biomarkers.

Fischer DB, William AH, Strauss AC, Unger ER, Jason L, Marshall GD Jr, Dimitrakoff JD.

Fatigue. 2014 Jun 1;2(2):93-109.

PMID:
24932428
[PubMed]
2.

Decreased basal ganglia activation in subjects with chronic fatigue syndrome: association with symptoms of fatigue.

Miller AH, Jones JF, Drake DF, Tian H, Unger ER, Pagnoni G.

PLoS One. 2014 May 23;9(5):e98156. doi: 10.1371/journal.pone.0098156. eCollection 2014.

PMID:
24858857
[PubMed - in process]
Free PMC Article
3.

Type-specific HPV and Pap test results among low-income, underserved women: providing insights into management strategies.

Saraiya M, Benard VB, Greek AA, Steinau M, Patel S, Massad LS, Sawaya GF, Unger ER.

Am J Obstet Gynecol. 2014 May 6. pii: S0002-9378(14)00438-4. doi: 10.1016/j.ajog.2014.05.001. [Epub ahead of print]

PMID:
24813971
[PubMed - as supplied by publisher]
4.

Human papillomavirus genotype prevalence in invasive vaginal cancer from a registry-based population.

Sinno AK, Saraiya M, Thompson TD, Hernandez BY, Goodman MT, Steinau M, Lynch CF, Cozen W, Saber MS, Peters ES, Wilkinson EJ, Copeland G, Hopenhayn C, Watson M, Lyu C, Unger ER.

Obstet Gynecol. 2014 Apr;123(4):817-21. doi: 10.1097/AOG.0000000000000171.

PMID:
24785610
[PubMed - indexed for MEDLINE]
5.

Human papillomavirus prevalence in oropharyngeal cancer before vaccine introduction, United States.

Steinau M, Saraiya M, Goodman MT, Peters ES, Watson M, Cleveland JL, Lynch CF, Wilkinson EJ, Hernandez BY, Copeland G, Saber MS, Hopenhayn C, Huang Y, Cozen W, Lyu C, Unger ER; HPV Typing of Cancers Workgroup.

Emerg Infect Dis. 2014 May;20(5):822-8. doi: 10.3201/eid2005.131311.

PMID:
24751181
[PubMed - in process]
Free PMC Article
6.

Prevaccine era human papillomavirus types 6, 11, 16 and 18 seropositivity in the USA, National Health and Nutrition Examination Surveys, 2003-2006.

Introcaso CE, Dunne EF, Hariri S, Panicker G, Unger ER, Markowitz LE.

Sex Transm Infect. 2014 Apr 19. doi: 10.1136/sextrans-2013-051490. [Epub ahead of print]

PMID:
24748563
[PubMed - as supplied by publisher]
7.

Population-based surveillance for cervical cancer precursors in three central cancer registries, United States 2009.

Flagg EW, Datta SD, Saraiya M, Unger ER, Peters E, Cole L, Chen VW, Tucker T, Byrne MJ, Copeland G, Silva W, Watson M, Weinstock H.

Cancer Causes Control. 2014 May;25(5):571-81. doi: 10.1007/s10552-014-0362-x. Epub 2014 Feb 28.

PMID:
24578200
[PubMed - in process]
8.

Human papillomavirus genotype prevalence in invasive penile cancers from a registry-based United States population.

Hernandez BY, Goodman MT, Unger ER, Steinau M, Powers A, Lynch CF, Cozen W, Saber MS, Peters ES, Wilkinson EJ, Copeland G, Hopenhayn C, Huang Y, Watson M, Altekruse SF, Lyu C, Saraiya M; HPV Typing of Cancer Workgroup.

Front Oncol. 2014 Feb 5;4:9. doi: 10.3389/fonc.2014.00009. eCollection 2014.

PMID:
24551592
[PubMed]
Free PMC Article
9.

Cross-sectional study of HPV-16 infection in a population-based subsample of Hispanic adults.

Ortiz AP, Unger ER, Muñoz C, Panicker G, Tortolero-Luna G, Soto-Salgado M, Otero Y, Suárez E, Pérez CM.

BMJ Open. 2014 Feb 4;4(2):e004203. doi: 10.1136/bmjopen-2013-004203.

PMID:
24496698
[PubMed]
Free PMC Article
10.

Prevalence of human papillomavirus types in invasive cervical cancers from 7 US cancer registries before vaccine introduction.

Hopenhayn C, Christian A, Christian WJ, Watson M, Unger ER, Lynch CF, Peters ES, Wilkinson EJ, Huang Y, Copeland G, Cozen W, Saber MS, Goodman MT, Hernandez BY, Steinau M, Lyu C, Tucker TT, Saraiya M.

J Low Genit Tract Dis. 2014 Apr;18(2):182-9. doi: 10.1097/LGT.0b013e3182a577c7.

PMID:
24477171
[PubMed - in process]
11.

CDC grand rounds: Reducing the burden of HPV-associated cancer and disease.

Dunne EF, Markowitz LE, Saraiya M, Stokley S, Middleman A, Unger ER, Williams A, Iskander J; Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2014 Jan 31;63(4):69-72.

PMID:
24476977
[PubMed - indexed for MEDLINE]
Free Article
12.

Overview of the CDC Cervical Cancer (Cx3) Study: an educational intervention of HPV testing for cervical cancer screening.

Benard VB, Saraiya M, Greek A, Hawkins NA, Roland KB, Manninen D, Ekwueme DU, Miller JW, Unger ER.

J Womens Health (Larchmt). 2014 Mar;23(3):197-203. doi: 10.1089/jwh.2013.4655. Epub 2013 Dec 31.

PMID:
24380501
[PubMed - indexed for MEDLINE]
13.

Reply to Groner et al and Pei et al.

Markowitz LE, Hariri S, Dunne EF, Steinau M, Unger ER.

J Infect Dis. 2014 Apr 15;209(8):1304-5. doi: 10.1093/infdis/jit835. Epub 2013 Dec 23. No abstract available.

PMID:
24368839
[PubMed - indexed for MEDLINE]
14.

Randomization modeling to ascertain clustering patterns of human papillomavirus types detected in cervicovaginal samples in the United States.

Querec TD, Gurbaxani BM, Unger ER.

PLoS One. 2013 Dec 18;8(12):e82761. doi: 10.1371/journal.pone.0082761. eCollection 2013.

PMID:
24367553
[PubMed - in process]
Free PMC Article
15.

Would young women attending sexually transmitted disease clinics benefit from human papillomavirus vaccination? An assessment of human papillomavirus DNA and seropositivity from human papillomavirus sentinel surveillance, 2003-2005.

Dunne EF, Flagg EW, Unger ER, Hsu K, Ghanen K, Kerndt P, Shlay JC, Koutsky LA, Datta DS, Panicker G, Zaidi A, Weinstock H, Markowitz LE.

Sex Transm Dis. 2014 Jan;41(1):46-9. doi: 10.1097/OLQ.0000000000000071.

PMID:
24326582
[PubMed - in process]
16.

Prevalence of cervical and oral human papillomavirus infections among US women.

Steinau M, Hariri S, Gillison ML, Broutian TR, Dunne EF, Tong ZY, Markowitz LE, Unger ER.

J Infect Dis. 2014 Jun 1;209(11):1739-43. doi: 10.1093/infdis/jit799. Epub 2013 Dec 5.

PMID:
24319284
[PubMed - indexed for MEDLINE]
17.

Urine-based human papillomavirus DNA testing as a screening tool for cervical cancer in high-risk women.

Mendez K, Romaguera J, Ortiz AP, López M, Steinau M, Unger ER.

Int J Gynaecol Obstet. 2014 Feb;124(2):151-5. doi: 10.1016/j.ijgo.2013.07.036. Epub 2013 Nov 1.

PMID:
24296266
[PubMed - in process]
18.

Population impact of HPV vaccines: summary of early evidence.

Hariri S, Markowitz LE, Dunne EF, Unger ER.

J Adolesc Health. 2013 Dec;53(6):679-82. doi: 10.1016/j.jadohealth.2013.09.018. Review.

PMID:
24263069
[PubMed - indexed for MEDLINE]
19.

Correction: HPV Prevalence among Women from Appalachia: Results from the CARE Project.

Reiter PL, Katz ML, Ruffin MT, Hade EM, Degraffenreid CR, Patel DA, Paskett ED, Unger ER.

PLoS One. 2013 Oct 25;8(10). doi: 10.1371/annotation/7a4cfd0a-cf77-430e-89a0-b2576268e2eb. eCollection 2013.

PMID:
24204499
[PubMed - as supplied by publisher]
Free PMC Article
20.

HPV prevalence among women from Appalachia: results from the CARE project.

Reiter PL, Katz ML, Ruffin MT, Hade EM, DeGraffenreid CR, Patel DA, Paskett ED, Unger ER.

PLoS One. 2013 Aug 30;8(8):e74276. doi: 10.1371/journal.pone.0074276. eCollection 2013.

PMID:
24023700
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk